311690.KS · CJ 바이오사이언스

South Korea · RS rating 8 · As of 2026-10-14

Price3,810.00 KRW
1-day change-1.4%
RS rating (overall / 1M / 3M / 12M)8 / 44 / 19 / 6
StageDeclining
Composite / Minervini / CANSLIM score16 / 2 / 9
Industry group (rank)Medical-Biomed/Biotech (95)
EPS growth Q/Q-21.2%
Sales growth Q/Q+14.7%
Distance from 52-week high+61.9%
Market cap (USD)$37.4M
Open South Korea in the interactive screener